BioCentury
ARTICLE | Clinical News

CEA-expressing VRP vaccine: Completed Phase I/II enrollment

May 25, 2009 7:00 AM UTC

AlphaVax completed enrollment of 24 patients in an open-label, dose-escalation, U.S. Phase I/ll trial evaluating the intramuscular vaccine given every 3 weeks for a minimum of 4 immunizations, with ad...